| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 68.4377 | 68 |
| GSM780708 | Untreated after 4 days (C2_1) | 67.7169 | 68 |
| GSM780709 | Untreated after 4 days (C3_1) | 60.2182 | 65 |
| GSM780719 | Untreated after 4 days (C1_2) | 57.7127 | 63 |
| GSM780720 | Untreated after 4 days (C2_2) | 65.406 | 67 |
| GSM780721 | Untreated after 4 days (C3_2) | 64.7027 | 67 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 61.8333 | 66 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 61.799 | 66 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 64.0248 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 65.4232 | 67 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 65.5927 | 67 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 56.8511 | 62 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 55.6931 | 60 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 64.1996 | 67 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 61.5577 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.2941 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 59.3664 | 64 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.3673 | 62 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 59.6122 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 55.2355 | 60 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.9925 | 51 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 66.4191 | 68 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 61.0311 | 65 |